Biogen (BIIB) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $3.0 billion.
- Biogen's Treasury Shares changed 0.0% to $3.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.0 billion for FY2025, which is 0.0% changed from last year.
- According to the latest figures from Q4 2025, Biogen's Treasury Shares is $23.8 million, which was down 0.0% from -$23.8 million recorded in Q2 2025.
- In the past 5 years, Biogen's Treasury Shares ranged from a high of $23.8 million in Q4 2021 and a low of -$23.8 million during Q1 2022
- For the 5-year period, Biogen's Treasury Shares averaged around -$4.1 million, with its median value being $2.2 million (2021).
- Within the past 5 years, the most significant YoY rise in Biogen's Treasury Shares was 0.0% (2021), while the steepest drop was 0.0% (2021).
- Quarter analysis of 5 years shows Biogen's Treasury Shares stood at $3.0 billion in 2021, then changed by 0.0% to $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025.
- Its Treasury Shares stands at $3.0 billion for Q4 2025, versus $3.0 billion for Q3 2025 and $3.0 billion for Q2 2025.